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1. Introduction 
Lymphedema is swelling due to excess accumulation of lymph in the tissues caused by 
inadequate lymph drainage (Mortimer, 2010). The protein-rich lymph accumulates in tissue 
when reabsorption is hindered or when the lymphatics are absent or blocked (Gaber, 2009). 
Lymphedema is most commonly seen on lower limbs (Figure 1), rarely on the upper limbs, 
and extremely rarely on the head or the trunk. The development of this process may take 
several years (Cohen et al, 2001). 
 
 
Fig. 1. Bilateral leg lymphedema. 
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The leading causes of lymphedema include cancer and therapy for malignant diseases, 
infections, chronic venous insufficiency, and congenital malformations (Planinšek Ručigaj et 
al, 2005). 
2. Etiology and pathogenesis of lymphedema 
Within the interstitial space – the space between tissue cells – fluid is always present. The 
amount of fluid depends on two factors: the amount introduced into the interstitial space, 
and the amount removed from it. Fluid enters the space from arterioles and venules; some 
returns to the venules, and the remainder is taken up by the lymphatics. In the normal 
physiologic state, entrance and exit are approximately equal, so that tissues retain their 
usual morphologic appearance and function. Edema (swelling) develops when the volume 
of interstitial fluid increases, either from increased inflow or decreased outflow, or both 
(Tretbar  et al, 2008). 
An imbalance between lymphatic flow and the capacity of lymphatic circulation (capillary 
filtration exceeding the capacity of lymphatic circulation) bring up to edema (Mortimer, 
1998). The protein constituents of static lymph fluid may cause inflammation and 
subsequent tissue fibrosis. In patients with lymphedema, the overlying skin may develop 
cobblestoning, as well as a verrucous or mossy appearance (Philips, 2008).  
Based on pathogenesis, one distinguishes two types of lymphedema: primary and 
secondary lymphedema (Gaber, 2009). 
2.1 Primary lymphedema 
Lymphedema arising from an intrinsic abnormality of the lymph-conducting pathways is 
referred to as primary lymphedema (Browse et al, 1985). The deficient lymphatics do not or 
can not propel the lymph in adequate amounts, and the fluid sequesters within the 
interstitial or lymphatic spaces (Tretbar et al, 2008). There is a simple classification by age of 
onset without reference to etiology or other clinical features into three types based on age at 
first appearance of disease: congenital lymphedema, which typically develops within two 
years of life, lymphedema praecox (present <35 years of age), and lymphedema tarda (first 
present >35 years of age). The problem can be unilateral or bilateral and may be familial or 
sporadic (Gaber 2009, Mortimer 2010, Moneta 2009). Primary lymphedema often occurs in 
the lower extremities, and affects women more often than men (Browse et al, 1985). 
An increasing understanding of the genetic basis of primary lymphedema has further 
changed classification and to some extent made the praecox and tarda categories redundant. 
For example in lymphoedema–distichiasis syndrome (LDS), the onset of lower-limb oedema 
can range from puberty to 40 years old despite the same cause, namely a mutation in the 
FOXC2 gene (Brice G et al, 2002). Conversely, LDS and Meige forms of primary 
lymphoedema can both present at puberty with similar lower limb lymphedema but have 
different genotypes and different mechanisms; LDS is associated with hyperplasia and valve 
reflux of collecting lymphatics whereas Meige's disease is associated with hypoplasia of 
collecting vessels. In the future, classification of lymphoedema is likely to be based on 
phenotype, unless the genotype is known (Mortimer 2010). 
The development of lymphangiography in the 1950s resulted in a radiological classification: 
aplasia (no formed lymph pathways found), hypoplasia (lymphatics smaller of fewer than 
normal) and hyperplasia (lymphatics larger and more numerous). Aplasia, hypoplasia and 
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hyperplasia refer to abnormalities in the main (leg) conducting lymph vessels as opacified 
on lymphangiography, and not to the initial lymphatics, which are not imaged with this 
method. Further investigation revealed types of lymphoedema where few, if any, lymph 
conducting vessels could be identified in the foot, but vessels were found to be normal 
further up the limb (Browse 1996).  
The causes of primary lymphedema are summarized in Table 1 (Mortimer 2010). 
 
Congenital onset Postpubertal onset 
Familial Sporadic Familial Sporadic 
Milroy’s disease Turner’s syndrome 
Distichiasis-
lymphedema 
Distal hypoplasia 
 
Noonan’s syndrome Meige’s disease Lymph reflux 
Neurofibromatosis 
 
Ilioinguinal node 
sclerosis 
Proteus syndrome 
Yellow nail 
syndrome 
Pure or mixed vascular 
lymphatic 
malformations 
 
Lymphangiomatosis 
Klippel-Trenaunay 
syndrome 
Mafucci’s syndrome 
Amniotic bands 
Table 1. Causes of primary lymphedema (Mortimer 2010) 
2.2 Secondary lymphedema 
Secondary lymphedema is swelling that follows some other incident or event, such as 
infection or injury (Tretbar 2008). The dysfunction of lymphatics in secondary lymphedema 
may be due to surgery, post-radiation fibrosis, infections, and primary or metastatic tumors, 
all causing lymphatic obstruction.  Secondary lymphedema is much more frequent than 
primary (Planinšek Ručigaj T, 2010). The causes are summarized in Table 2 (Gaber 2009, 
Mortimer 2010). 
In the Western world, surgery and radiation therapy for cancer (eg. breast and pelvic 
carcinoma, melanoma, head/neck cancer, Caposi sarcoma) are the leading cause of 
secondary lymphedema (Figures 2 and 3.) Lymphedema may appear as late as 30 years after 
the intervention. Due to increased cancer survival, the incidence of lymphedema is on the 
rise (Rockson 2001, Carpentier, 2002). Lymphatic tumors (e.g. lymphoma, sarcoma) may also 
cause lymphedema, however infrequently (Planinšek Ručigaj 2010). 
Worldwide, venous insufficiency is a highly prevalent condition and is commonly 
accompanied by edema. It is assumed that venous edema is the sole consequence of 
increased capillary filtration from venous hypertension. As lymph drainage is the main 
buffer against edema, it is in fact the failure of local lymphatics to compensate for the 
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Tumour 
Cancer surgery 
Radiotherapy 
Kaposi’s sarcoma 
Infiltrative cancer 
Lymphoma 
Relapsed tumour 
Infection 
Filariasis 
Erysipelas, cellulitis, tuberculosis, lymphogranuloma 
inguinale, lice 
Inflammation 
Lymphatic occlusion: podoconiosis, pretibial myxedema, 
dermatitis (eg. hand eczema), rosacea 
Granulomatous disease: orofacial granulomatosis, Crohn 
disease, sarcoidosis 
Vascular 
Venous disease: postthrombotic syndrome, chronic venous 
insufficiency 
Trauma 
Surgery: lymphadenectomy, vein harvesting 
Self-harm: tourniquet application, intravenous drug abuse, 
Secretan syndrome 
Accident: degloving injury, burns 
Functional Static (prolonged standing), premenstrual, pregnancy 
Medications 
Oral contraceptives, psoralens, corticosteroids, 
antihypertensives, diuretics 
Table 2. Causes of secondary lymphedema (Gaber 2009, Mortimer 2010) 
increased lymph load from filtration that leads to edema. The small and precollecting 
lymphatics of the skin and subcutaneous tissues of the lower leg are damaged by prolonged 
venous hypertension. Lymphedema develops with chronic lipodermatosclerosis, with or 
without venous ulceration. Lymphedema associated with venous disease can give rise to the 
most gross swelling and skin changes owing to the combined effect of impaired lymph 
drainage and the increased lymph load (capillary filtration) (Mortimer 2010). 
The leading cause of secondary lymphedema in the third world is filariasis, a worm 
(nematode) infection. Lymphatic filariasis is caused by Wuchereria bancrofti, Brugia malayi, or 
Brugia timori. The infection is transmitted by mosquitoes and other arthropodes. The adult 
worms reside in lymphatic channels or lymph nodes, where they cause lymphatic dilatation 
and thickening of the vessel walls with subsequent fibrosis, lymphatic obstruction and 
lymphedema (elephantiasis tropica) (Rockson 2001, Neese 2000).  
www.intechopen.com
 
Lymphedema: Clinical Picture, Diagnosis and Management 293 
 
Fig. 2. Secondary lymphedema of the left arm after breast cancer surgery, including axillary 
lymphadenectomy. 
 
Fig. 3. Secondary lymphedema of the left breast after axillary lymphadenectomy. 
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3. Clinical picture and staging of lymphedema 
Lymphedema differs from all other edemas (in which increased capillary filtration is the 
major factor) in that cells, proteins, lipids and debris accumulate in addition to water. This 
results in a ‘solid’ as well as a ‘fluid’ component to the swelling, so giving rise to the brawny 
nature of the edema which does not readily pit (Mortimer 1995). However, during the early 
stages, the swelling of lymphedema may be soft and pitting, therefore indistinguishable 
from other causes of oedema. Only during the later stages it develops the characteristics of 
‘true’ lymphedema (Planinšek Ručigaj 2005). 
The Stemmer-Kaposi sign is a helpful clinical sign in diagnosing lymphedema. It refers to 
the fact that, with lymphedema, the skin over the metatarsal-phalangeal joint of the second 
toe cannot be pinched up into a fold (Figure 4) (Stemmer 1976). 
In lymphedema, skin creases become enhanced and hyperkeratosis develops. Dilatation of 
upper dermal lymphatics with consequent organization and fibrosis gives rise to 
papillomatosis. As dermal lymph stasis progresses, these skin changes become more 
marked and are referred to as elephantiasis. Occasionally, the tissue fibrosis and thickening 
may become so marked in the later stages of lymphedema that pitting is absent. 
 
  
Fig. 4. The Stemmer-Kaposi sign. In lymphedema, the skin over metatarsal-phalangeal joint 
of the second toe can not be pinched into a fold (left, positive sign). In the absence of 
lymphedema (right), the skin can be readily pinched into a fold (negative sign). 
Limb swelling leads to discomfort, limb heaviness, pain, reduced mobility and, on 
occasions, impaired function. The size and weight of affected limbs can result in 
secondary musculoskeletal complications such as back pain and joint problems. 
Thickening of the skin causes pseudoscleroderma and consequently impairs small-joint 
mobility. The difficulty in finding clothes or shoes to fit create social problems. Poor 
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footwear will further compound the swelling by discouraging a normal gait or enough 
exercise. Leakage of lymph through the skin (lymphorrhoea) may occur from engorged 
dermal lymphatics (Mortimer 2010).  
3.1 Staging of lymphedema 
Regardless of etiology, lymphedema is clinically staged by the extent of visible tissue 
degradation (Moneta 2009). 
Latent or subclinical (stage 0) lymphedema may persist for months to years without any 
clinical evidence of lymphatic disturbance. Trigger events, e.g. insect sting, physical 
exertion, injuries or surgery, inflammation or warming of the limb may cause some minor 
foot edema or even severe limb edema, which is either reversible or may, with additional 
lymphatic overload, proceed to the following stage. In stage I, the edema is reversible, soft, 
disappearing spontaneously overnight or, with compression therapy, during the day. The 
skin is smooth, with small pits. Stage I may persist for several years. However, if left 
untreated, it sooner or later proceeds to the chronical stage II. 
During the stage II, edema persists despite limb elevation. In the early stage, edema is still 
pittng, later the edema is non-pitting, elastic. The skin feels harder, fibrotic. This is the phase 
can not be reversed spontaneously without therapy. 
During the stage III, which is also called elephanthiasis, the edema is enormous. The skin 
shows trophic changes (fibrosis, hyperkeratoses, papillomatosis, hyperpigmentations, 
lymphorea, ulcerations) and is prone to bacterial and fungal infections. The condition may 
only partly improve with appropriate therapy. (International Society of Lymphology 2003, 
Cohen 2001, Rockson 2001).  
Lymphedema may be further classified by the volume of edema (minimal, moderate, or 
severe); speed of progression (benign, malignant type); and localization (distal, proximal 
type). 
3.2 Complications of lymphedema 
Chronic lymphedema is often complicated by recurrent lymphangitis/cellulitis and in the 
long-standing disease, numerous neoplastic complications have been described (Szuba & 
Rockson, 1998).  
The accumulated fluid and proteins serve as a perfect culture medium for bacterial growth. 
Impaired lymphatic drainage impedes the local immune response, which, in turn, promotes 
bacterial and fungal invasion (Mallon & Ryan, 1994). The infection further impairs 
lymphatic drainage and the aggravation of the edema usually persists after the infection 
resolves. With recurrent infections, there is progressive damage of the lymphatic capillaries 
(Bollinger 1993). The clinical picture may vary from acute attacks of a rapidly progressive 
infection (high fever, chills and general malaise, with localized edema, erythema and 
characteristic changes of peau d’orange) to a subclinical course with, at best, subtle skin 
changes and normal body temperature. Recurrent attacks of cellulitis damage existing 
cutaneous lymphatics, worsen skin changes and further aggravate existing edema. Acute 
attacks of cellulitis usually resolve quickly after antibiotic therapy but tend to reoccur, 
becoming more resistant to antibiotic therapy when they do. Prophylaxis against cellulitis 
includes meticulous skin care, avoidance of minor trauma and the prophylactic use of 
antibiotics (Olszewski & Jamal, 1996, VanScoy & Wilkowske 1992).  
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In rare cases, chronic lymphedema may be complicated by the development of malignant 
tumors within the involved limb. Malignant tumors of a lymphedematous extremity can 
evolve from lymphedema of any etiology: postsurgical, traumatic, filarial and primary, but 
the phenomenon is most often observed in postmastectomy edema of the arm, with a 
described frequency of 0.45% (Szuba & Rockson 1998). The best-known associated 
malignancy is lymphangiosarcoma, however, other tumours have been recorded and 
include basal cell carcinoma, lymphoma, melanoma, malignant fibrous histiocytoma and 
Kaposi's sarcoma (Mortimer 2010). 
4. Diagnosis of lymphedema 
Lymphedema can be surprisingly difficult to diagnose, especially in its early stages. Without 
a proper diagnosis, therapy is often delayed, allowing secondary fibrosis and lipid 
deposition to take place. Early treatment often results in rapid clinical improvement and 
prevents progression to the chronic phase of the disease (Szuba et al 2003).  
The diagnosis of lymphedema requires careful history and clinical assessment, and 
exclusion of other causes of oedema. 
History should include: 
 Duration (acute vs. chronic) and previous therapy of edema; 
 Pain, fatigue, paresthesias, mobility disturbances of the affected limb; 
 Trigger events,  
 Concurrent systemic signs/symptoms; 
 Personal history of tumours, tumour therapy, postoperative complications; 
 Personal history of injuries, surgery, infections, chronic venous insufficiency, deep 
venous thrombosis; 
 Personal history of malabsorption syndrome, thyroid disease, cardiovascular disease, 
arterial hypertension, rheumatoid arthritis, transient obesity and lipedema, 
cerebrovascular disease, peripheral arterial disease, diabetes; 
 Past and current medications, allergies; 
 Occupation, hobbies; 
 Family history. 
Clinical assessment should include: 
 Appearance of the skin (dry, flaky skin, fibrosis, papillomatosis, hyperkeratosis, 
hyperpigmentation, lymphorrhea, ulceration, warmth, erythema, pain of the affected 
area); 
 Localization of edema; 
 Assessment of the oedema (soft/hard or elastic/nonelastic);  
 Comparison of limb diameters at several points (at the ankle, 10 cm above the upper 
and 10 cm below the lower margin of the patella); 
 Stemmer-Kaposi sign – a diagnostic test that involves pinching of the skin on the upper 
surface of the second toe. In a negative result, it is possible to grasp a thin fold of tissue. 
In a positive result, which is characteristic of lymphedema, a plateau or a small pit is 
formed on the upper surface of the second toe when the tissue is pinched; 
 Lymph node palpation; 
 Mobility of the edematous limb; 
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 Presence of peripheral pulses, varicose veins; 
 Inspection of feet and interdigital spaces, ingrowing nails, 
 Systemic signs/symptoms (eg.  fever, dyspnea etc.) 
4.1 Diagnostic tests in lymphedema 
In many cases of advanced sustained disease, a typical history and characteristic clinical 
presentation establish the diagnosis of lymphedema with near certainty. Nevertheless, 
additional tests are sometimes necessary to confirm the presence of impaired lymphatic flow 
and/or the typical pattern of abnormal fluid distribution within the tissues. The diagnosis is 
more difficult to ascertain in the early stages, particularly when edema is mild or 
intermittent (Szuba & Rockson 1998). 
Lymphoscintigraphy is the golden standard of imaging in diagnosing lymphedema. It offers 
an objective and reliable approach to diagnose and characterize the severity of lymphedema 
(Szuba et al 2003). Other available tests include indirect and direct lymphography, 
lymphatic capillaroscopy, magnetic resonance imaging (MRI), axial tomography, and 
ultrasonography (Szuba & Rockson 1998). Magnetic resonance lymphangiography is a new, 
and also promising, imaging modality of the lymphatic system (Peller et al. 2009). 
Lymphoscintigraphy, broadly described as an assessment of the lymphatic clearance of 
injected radioactive particles, was initially developed in the 1950s (Moneta 2009). Particles 
smaller than a few nanometers usually leak into blood capillaries, whereas larger particles 
(up to about 100 nm) can enter the lymphatic capillaries and be transported to lymph nodes 
(Moghimi & Bonnemain 1999). The optimal colloidal size for lymphoscintigraphy is believed 
to be approximately 50–70 nm (Strand & Bergqvist 1989). Technetium (99Tcm) labelled tracers 
such as sulphur colloid, microaggregated albumin and antimony sulphide are the most 
commonly used agents. In this minimally invasive procedure, intradermal or subcutaneous 
injection of the chosen radiolabeled tracer is performed, followed by subsequent gamma 
camera monitoring. Subfascial injection of the radiotracer may also be performed to analyse 
deep lymphatic system. The protocol for lymphoscintigraphy is not standardized and differs 
among diagnostic centers. Differences include the choice of radiotracer, the type and site of 
injection, the use of dynamic and static acquisition, and the acquisition times themselves. 
(Szuba 2003). A normal lymphoscintigram of the lower extremities is shown in Fig. 5, 
whereas Fig. 6 features a lymphoscintigraphic picture of lymphedema. 
In extremity lymphedema assessment, a small volume of tracer (approximately 0.2 ml) is 
injected subcutaneously into the first to third web spaces on each hand or foot. Both limbs 
are examined, even if one appears normal, to detect sub-clinical abnormalities, provide 
internal comparison and monitor injection and camera technique. Images are acquired using 
a high-resolution, parallel hole, collimator. The arrival of tracer at the knees and groin (or 
elbows and axillae) is timed. A transmission scan using a flood source may be useful for 
anatomical localization. Quantitative parameters derived from tracer clearance data can be 
used to detect incipient lymphedema. After 30 min, if no groin (or axillary) activity is 
demonstrated, the patient is encouraged to mobilize/stress their limbs briefly. Lower 
extremity stress manoeuvres include walking, limb massage or bicycle exercise. For upper 
limb stressing, repetitive squeezing of a rubber ball, use of a hand-grip or massage can be 
used. They are then re-imaged to see if the proximal lymphatic system has been 
demonstrated. If there is still no activity, patients are encouraged to mobilize for several 
hours and delayed imaging is performed after 3–4 h (Scarsbrook et al 2007). 
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Fig. 5. Radioisotopic lymphography of the lower extremities in a patient with normally 
developed lymphatic system and normal lymphatic circulation (left, PA projection, right, AP 
projection). The radioindicator application site is seen as a large star-shaped activity in the 
lower part of the picture. Activity within the lymphatic vessels of the lower extremities can 
be observed, from the application site of the radioindicator on the dorsa of the feet, to the 
inguinal region, including several ingunal and abdominal lymph nodes. The lymphatic 
system of both extremities is virtually symmetrical. Image and interpretation courtesy of 
Marko Grmek. 
5. Therapy of lymphedema 
For decades, lymphedema has been thought by many clinicians to be non-curable and also 
largely untreatable. There now exist data supporting many types of successful treatment 
interventions, including medical and physical therapy (Gamble et al 2009). Surgery is not a 
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preferred treatment modality, but may be useful in selected cases. However, at the moment, 
there is no consensus on the therapy of lymphedema. Therapy should be tailored 
individually to the patient's clinical situation, history, and any coexisting illnesses, e.g. 
cancer. The aims of therapy are to reduce edema, to prevent its further accumulation, and to 
prevent any complications (e.g. infections). Patient compliance is of crucial importance, 
making continuous patient education and encouragement essential parts of management. 
(Planinšek Ručigaj et al 2010) Therefore, it is central to the management of lymphedema that 
patients get to understand their condition and know what they can do for themselves.  Only 
then can a high level of motivation and compliance with treatment be generated. 
 
 
 
 
 
 
 
 
 
Fig. 6. Radioisotopic lymphography in a patient with absent lymphatic circulation in the 
right lower extremity (left, PA projection, right, AP projection). A star-shaped activity at the 
radioisotope application site is seen on both feet, and the activity in lymphatic vessels and 
nodes on the left side. There is no activity in the lymphatic vessels or lymph nodes of the 
right lower extremity. Image and interpretation courtesy of Marko Grmek. 
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5.1 Lymphedema risk factor management and risk reduction measures 
Management of lymphedema should always include management of lymphedema risk 
factors and risk reduction measures (EWMA 2005, Planinšek Ručigaj 2005, Gamble et al 
2009). 
Other (accompanying) causes of edema must continue to be in the forefront of the clinician’s 
thougts in order not to neglect potentially dangerous and reversible causes. Deep venous 
thrombosis, recurrent malignancy, and active infection must be considered and ruled out as 
potential causes prior to initial treatment, and periodically thereafter. Cardiopulmonary, 
renal, or hepatic dysfunction must also be considered  (Gamble et al 2009). 
Meticulous skin care is of utmost importance to avoid scaling and cracking, and minimizing 
the risk for secondary bacterial of fungal infection. The skin should be daily washed with 
soap and water, and treated with an emollient cream to keep the protective skin barrier. An 
individually tailored exercise regimen should be recommended. Patients after cancer 
surgery should be monitored for the development of lymphedema, and treated as soon as 
possible (Planinšek Ručigaj et al 2010). 
The patients with lymphedema should avoid injury to the affected extremity, including 
injections and insect stings, and temperature extremes, whether hot or cold, which can 
create vascular challenge and increase lymphatic load. Tight consctriction and excessive 
overuse should also be avoided (Gamble  et al 2009). 
Increased body mass index (BMI) is a statistically significant predisposing factor for patients 
at risk for lymphedema as well (Soran et al 2010, Kizer et al 2011). Thus, a diet which 
maintains weight, or even promotes weight reduction, is encouraged to minimize 
development of edema (EWMA 2005, Gamble et al 2009). 
5.2 Compression and physical therapy of lymphedema 
The key treatment programme for lymphedema, known as decongestive lymphatic 
therapy, involves a combination of skin care, manual lymphatic drainage, inelastic multi-
layer compression bandaging and exercise. Although this programme of care is well 
established, there is little understanding of how the different treatment components work 
or how to optimise the effects. Much of the evidence on how compression works is based 
on research into venous disease, which has been extrapolated to lymphedema (EWMA 
2005). 
Several studies have shown an impressive reduction in swelling as a result of compression  
(Badger et al 2004, McNeely 2004) but few have tried to elucidate the mechanism of action 
for this improvement. The following mechanisms may explain how compression reduces 
volume in a lymphedematous limb: 
 reduction in capillary filtration 
 shift of fluid into non-compressed parts of the body 
 increase in lymphatic reabsorption and stimulation of lymphatic transport 
 improvement in the venous pump in patients with veno-lymphatic dysfunction 
 breakdown of fibrosclerotic tissue (EWMA 2005). 
Compression therapy for lymphedema is based mainly on the use of elastic, short-stretch 
bandages, which has been clinically endorsed by only one randomised controlled trial that 
showed a consistently greater volume reduction in lymphedematous arms with short-
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stretch multi-layer bandages compared to hosiery (Badger 2000). The summary of 
therapeutic recommendations for lymphedema by stages is shown in Table 3. 
 
Stage I  1. Evacuation of edema: long-stretch bandages/adhesive or nonadhesive 
short-stretch bandages and/or manual lymphatic drainage 
2. Maintenance:  medical compression stockings class II 
Stage II  1. Evacuation of edema: adhesive or nonadhesive short-stretch bandages 
and/or manual lymphatic drainage 
2. Maintenance:  medical compression stockings class III/IV 
Stage III  1. Evacuation of edema: adhesive or nonadhesive short-stretch bandages 
and/or manual lymphatic drainage 
2. Maintenance:  medical compression stockings class III/IV 
Table 3. Recommended therapeutic interventions in lymphedema by stages (EWMA 2005). 
6. Conclusion 
Lymphedema is a chronic, progressive swelling of a part of the body, usually a limb. It may 
appear secondary to other diseases or as an isolated process. Lymphedema is most 
commonly seen on lower limbs, rarely on the upper limbs, and extremely rarely on the head 
or the trunk.  
Ethiopathogenetically, lymphedema is classified into primary and secondary forms. Primary 
lymphedema may be hereditary or sporadic. Edema builds up due to lymphovascular or 
lymphonodular anomalies.  In secondary lymphedema, which is much more common than 
the primary forms, the dysfunction of lymphatics is secondary due to other causes, such as 
infections, surgery, post-radiation fibrosis, and primary or metastatic tumors, all causing 
lymphatic obstruction. The leading cause of secondary lymphedema in the third world is 
filariasis, a worm (nematode) infection. Surgery and radiation therapy for cancer are the 
leading cause of secondary lymphedema in the Western world.  
In some cases of lymphedema, particularly during the early stages, diagnostic tests may be 
necessary to confirm the lymphatic disturbance or point to the differential diagnosis. 
Lymphoscintigraphy (isotope lymphography) is the golden standard of imaging in 
diagnosing lymphedema. Lymphoscintigraphy involves the interstitial (dermis or subcutis) 
injection of a radio-labelled protein or colloid. Radioactivity, measured using a wide field-
of-view gamma-camera, is determined over the injection site depot and at regions of interest 
over vessels or nodes. Measurement of transit times and time activity curves permit 
quantitative analysis of lymph drainage. Measurement of tracer uptake within axillary or 
inguinofemoral lymph nodes at a specified tme following a standardized exercise routine 
will discriminate lymphedema from edema of non-lymphatic origin. 
At the moment, there is no consensus on the therapy of lymphedema. Therapy should be 
tailored individually to the patient's clinical situation, history, and any coexisting illnesses, 
e.g. cancer. The aims of therapy are to reduce edema, to prevent its further accumulation, 
and to prevent any complications (e.g. infections). Patient compliance is of crucial 
importance, making continuous patient education and encouragement essential parts of 
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management. Edema should be reduced as early as possible, using compression therapy 
and/by manual lymph drainage. During improvement, compression stockings are required 
to maintain the improved condition. 
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